News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,400 Results
Type
Article (18389)
Company Profile (78)
Press Release (249933)
Multimedia
Podcasts (22)
Webinars (5)
Section
Business (76736)
Career Advice (656)
Deals (13604)
Drug Delivery (38)
Drug Development (43648)
Employer Resources (76)
FDA (6696)
Job Trends (6409)
News (139841)
Policy (11090)
Tag
Academia (1285)
Academic (1)
Accelerated approval (2)
Adcomms (14)
Allergies (38)
Alliances (21614)
ALS (44)
Alzheimer's disease (505)
Antibody-drug conjugate (ADC) (115)
Approvals (6730)
Artificial intelligence (131)
Autoimmune disease (12)
Automation (4)
Bankruptcy (104)
Best Places to Work (5566)
BIOSECURE Act (7)
Biosimilars (54)
Biotechnology (61)
Bladder cancer (71)
Brain cancer (23)
Breast cancer (235)
Cancer (1865)
Cardiovascular disease (82)
Career advice (553)
Career pathing (15)
CAR-T (103)
Cell therapy (245)
Cervical cancer (16)
Clinical research (36737)
Collaboration (456)
Company closure (1)
Compensation (127)
Complete response letters (2)
COVID-19 (1266)
CRISPR (18)
C-suite (134)
Cystic fibrosis (22)
Data (1365)
Decentralized trials (1)
Denatured (7)
Depression (16)
Diabetes (113)
Diagnostics (2663)
Digital health (6)
Diversity (6)
Diversity, equity & inclusion (30)
Drug discovery (67)
Drug pricing (46)
Drug shortages (17)
Duchenne muscular dystrophy (33)
Earnings (25092)
Editorial (22)
Employer branding (7)
Employer resources (71)
Events (40014)
Executive appointments (378)
FDA (7311)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (328)
Gene editing (35)
Generative AI (11)
Gene therapy (125)
GLP-1 (332)
Government (1524)
Grass and pollen (2)
Guidances (60)
Healthcare (8597)
Huntington's disease (8)
IgA nephropathy (9)
Immunology and inflammation (63)
Indications (16)
Infectious disease (1330)
Inflammatory bowel disease (74)
Inflation Reduction Act (5)
Influenza (20)
Intellectual property (38)
Interviews (113)
IPO (5803)
IRA (24)
Job creations (1117)
Job search strategy (484)
Kidney cancer (11)
Labor market (10)
Layoffs (188)
Leadership (11)
Legal (1911)
Liver cancer (54)
Lung cancer (287)
Lymphoma (111)
Machine learning (3)
Management (24)
Manufacturing (105)
MASH (39)
Medical device (4105)
Medtech (4107)
Mergers & acquisitions (8056)
Metabolic disorders (272)
Multiple sclerosis (46)
NASH (16)
Neurodegenerative disease (26)
Neuropsychiatric disorders (5)
Neuroscience (748)
NextGen: Class of 2025 (2680)
Non-profit (1959)
Now hiring (7)
Obesity (129)
Opinion (70)
Ovarian cancer (69)
Pain (42)
Pancreatic cancer (68)
Parkinson's disease (69)
Partnered (8)
Patents (62)
Patient recruitment (59)
Peanut (18)
People (26266)
Pharmaceutical (21)
Pharmacy benefit managers (9)
Phase I (10866)
Phase II (15870)
Phase III (13128)
Pipeline (701)
Policy (69)
Postmarket research (1366)
Preclinical (3794)
Press Release (30)
Prostate cancer (86)
Psychedelics (11)
Radiopharmaceuticals (176)
Rare diseases (154)
Real estate (1919)
Recruiting (27)
Regulatory (8664)
Reports (19)
Research institute (1306)
Resumes & cover letters (86)
Rett syndrome (1)
RSV (25)
Schizophrenia (37)
Series A (71)
Series B (39)
Service/supplier (3)
Sickle cell disease (28)
Special edition (3)
Spinal muscular atrophy (73)
Sponsored (7)
Startups (1690)
State (1)
Stomach cancer (12)
Supply chain (20)
Tariffs (11)
The Weekly (15)
Vaccines (373)
Venture capitalists (18)
Weight loss (85)
Women's health (18)
Worklife (7)
Date
Today (74)
Last 7 days (405)
Last 30 days (1343)
Last 365 days (14739)
2025 (5217)
2024 (15826)
2023 (17749)
2022 (23062)
2021 (24439)
2020 (22224)
2019 (19677)
2018 (14953)
2017 (14451)
2016 (13615)
2015 (15635)
2014 (10740)
2013 (8104)
2012 (8705)
2011 (9072)
2010 (7938)
Location
Africa (296)
Alabama (22)
Alaska (5)
Arizona (54)
Arkansas (4)
Asia (19841)
Australia (3215)
California (2739)
Canada (741)
China (374)
Colorado (95)
Connecticut (112)
Delaware (123)
Europe (45437)
Florida (361)
Georgia (84)
Idaho (19)
Illinois (262)
India (17)
Indiana (119)
Iowa (5)
Japan (129)
Kansas (39)
Kentucky (13)
Louisiana (6)
Maine (14)
Maryland (391)
Massachusetts (2056)
Michigan (51)
Minnesota (129)
Missouri (22)
Montana (11)
Nebraska (10)
Nevada (25)
New Hampshire (20)
New Jersey (798)
New Mexico (9)
New York (763)
North Carolina (317)
Northern California (1264)
Ohio (80)
Oklahoma (4)
Oregon (9)
Pennsylvania (531)
Puerto Rico (3)
Rhode Island (8)
South America (442)
South Carolina (9)
Southern California (1083)
Tennessee (24)
Texas (406)
United States (9868)
Utah (66)
Virginia (38)
Washington D.C. (12)
Washington State (282)
Wisconsin (21)
268,400 Results for "gynecologic oncology group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
German Gynecological Oncology Group (AGO) Recognizes BluePrint® in Breast Cancer Guidelines
Agendia®, Inc. announced that the company’s 80-gene molecular subtyping assay, BluePrint®, is now included in the latest version of German Gynecological Oncology Group guidelines.
April 11, 2024
·
5 min read
Press Releases
Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
February 21, 2025
·
8 min read
Press Releases
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
March 17, 2025
·
9 min read
Press Releases
JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups
April 14, 2025
·
5 min read
Press Releases
Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
March 3, 2025
·
2 min read
Press Releases
IMUNON Announces Data from Phase 1/2 Trial Evaluating Intraperitoneal IMNN-001 in Combination with Neoadjuvant Chemotherapy in Newly Diagnosed Patients with Advanced Epithelial Ovarian Cancer to be Published in Gynecologic Oncology
May 7, 2025
·
7 min read
Press Releases
Allarity Therapeutics Announces Presentation of Phase 2 Clinical Data from Ongoing Trial in Advanced Ovarian Cancer Patients at the 2025 Annual Meeting for the Society of Gynecologic Oncology
March 17, 2025
·
8 min read
Press Releases
World Ovarian Cancer Coalition Launches Global Expert Advisory Group on Ovarian Cancer
May 8, 2025
·
4 min read
Biotech Bay
Moon Surgical Expands to Gynecological Surgery
The Franche-Comté Polyclinic, part of ELSAN, the leading private hospital group in France, and Moon Surgical, a French-American pioneer in collaborative robotics, announced that the Maestro System is now being used clinically in gynecological laparoscopic procedures.
April 3, 2024
·
2 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
1 of 26,840
Next
